Targeted clinical research to address select viral infections

Ended Definitive Contract Awarded Last action

Contract number
HHSN272201600017C
Awardee
Awarding agency
Obligated
$5,253,357

Award facts

Opportunity
Contract value 46% obligated
  • $5,253,356.65 Current, with exercised options
  • $11,509,617.65 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 13 offers Negotiated Proposal / Quote
Pricing
Cost No Fee
Place of performance
Birmingham, AL 35294, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00014 -$5,367
Other Administrative Action P00013 $0
Other Administrative Action P00012 $0
Other Administrative Action P00011 $0
Funding Only Action P00010 -$731,248
Other Administrative Action P00009 $0
Other Administrative Action P00008 $0
Change Order P00007 $2,579,355
Funding Only Action P00006 -$306,079
Change Order P00005 · To conduct a clinical study on congenital cytomegalovirus infection in pediatric patients. $0
Other Administrative Action 4 · Option period one: 04/04/2017 - 12/03/2020. Targeted clinical research to address select viral infections. $0
Change Order 2 $0
Exercise an Option 1 $2,608,666
Other Administrative Action 3 $0
Original award $1,108,030
Show all 15

About this award

The National Institute of Allergy and Infectious Diseases awarded an $11.51 million definitive contract to University Of Alabama At Birmingham on June 30, 2016, for targeted clinical research to address select viral infections, specifically to conduct a clinical study on congenital cytomegalovirus infection in pediatric patients. The contract carries cost-plus-no-fee pricing and extends through May 31, 2026.

Place of performance is Birmingham, AL 35294. The originating solicitation describes a clinical study protocol focused on CMV infection in pediatric populations, encompassing protocol design, patient recruitment and enrollment, specimen collection and analysis, and clinical follow-up procedures.

The contract engages a multi-site clinical trial network including St Jude Children's Research Hospital (laboratory testing and transcriptomic analysis of protocol specimens), Research Institute At Nationwide Children's Hospital (clinical protocol site operations and patient enrollment), University Of Tennessee Health Science Center (clinical site operations), University Of Pittsburgh (clinical site operations), The Washington University (clinical site operations), University Of Utah (clinical site operations), University Of Louisville (clinical site operations), The Administrators Of Tulane Educational Fund (clinical site operations), Connecticut Children's Medical Center (clinical site operations), The Charlotte-Mecklenburg Hospital Authority doing business as Atrium Health (clinical site operations), Arkansas Children's Research Institute (clinical site operations), and University Of Mississippi Medical Center (clinical site operations).

Service Contract Inventory data reflects actual government-paid labor spanning FY2021–FY2025. FY2022 recorded peak invoiced activity at $1.1 million across 5.4 FTEs and 11,309 contractor hours at a derived rate of $101.67 per hour. FY2025 (most recent) shows $530 thousand invoiced against 2.0 FTEs. Derived government-paid hourly rates have risen from $93.56 per hour in FY2021 to $216.34 per hour in FY2024, reflecting shift toward senior clinical and research labor. The prime contractor self-performed all reported hours across the reporting period with no subcontractor engagement on SCI-reportable deliverables.

Subawards

Subcontractor Amount Awarded
ST Jude Children's Research Hospital Inc. IGF::OT::IGF - TARGETED CLINICAL RESEARCH TO ADDRESS SELECT VIRAL INFECTIONS The subcontractor will perform laboratory testing of protocol specimens to obtain… $11,550
Research Institute At Nationwide Children's Hospital IGF::OT::IGF - TARGETED CLINICAL RESEARCH TO ADDRESS SELECT VIRAL INFECTIONS Participate in clinical protocol and site development, begin patient screening… $6,665
University Of Tennessee IGF::OT::IGF - TARGETED CLINICAL RESEARCH TO ADDRESS SELECT VIRAL INFECTIONS Participate in clinical protocol site development teleconferences, begin patient… $3,950
Research Institute At Nationwide Children's Hospital IGF::OT::IGF - TARGETED CLINICAL RESEARCH TO ADDRESS SELECT VIRAL INFECTIONS Participate in clinical protocol and site development, begin patient screening… $5,540
Connecticut Children's Medical Center TO CONDUCT A CLINICAL STUDY ON CONGENITAL CYTOMEGALOVIRUS INFECTION IN PEDIATRIC PATIENTS. Participate in clinical protocol site development teleconferences,… -$42,190
University Of Louisville TO CONDUCT A CLINICAL STUDY ON CONGENITAL CYTOMEGALOVIRUS INFECTION IN PEDIATRIC PATIENTS. Participate in clinical protocol site development teleconferences,… -$25,800
The Administrators Of Tulane Educational Fund TO CONDUCT A CLINICAL STUDY ON CONGENITAL CYTOMEGALOVIRUS INFECTION IN PEDIATRIC PATIENTS. Participate in clinical protocol site development teleconferences,… -$29,780
The Washington University TO CONDUCT A CLINICAL STUDY ON CONGENITAL CYTOMEGALOVIRUS INFECTION IN PEDIATRIC PATIENTS. Participate in clinical protocol site development teleconferences,… -$34,970
University Of Tennessee TO CONDUCT A CLINICAL STUDY ON CONGENITAL CYTOMEGALOVIRUS INFECTION IN PEDIATRIC PATIENTS. Participate in clinical protocol site development teleconferences,… -$16,915
University Of Pittsburgh - Of The Commonwealth System Of Higher Education TO CONDUCT A CLINICAL STUDY ON CONGENITAL CYTOMEGALOVIRUS INFECTION IN PEDIATRIC PATIENTS. Participate in clinical protocol site development teleconferences,… $8,770
Research Institute At Nationwide Children's Hospital TO CONDUCT A CLINICAL STUDY ON CONGENITAL CYTOMEGALOVIRUS INFECTION IN PEDIATRIC PATIENTS. Participate in clinical protocol and site development, begin… $19,280
The Charlotte-Mecklenburg Hospital Authority TO CONDUCT A CLINICAL STUDY ON CONGENITAL CYTOMEGALOVIRUS INFECTION IN PEDIATRIC PATIENTS. Participate in clinical protocol and site development; begin… -$30,395
University Of Utah TO CONDUCT A CLINICAL STUDY ON CONGENITAL CYTOMEGALOVIRUS INFECTION IN PEDIATRIC PATIENTS. Participate in clinical protocol site development teleconferences,… -$31,725
University Of Louisville TO CONDUCT A CLINICAL STUDY ON CONGENITAL CYTOMEGALOVIRUS INFECTION IN PEDIATRIC PATIENTS. Participate in clinical protocol site development teleconferences,… $20,000
University Of Tennessee TO CONDUCT A CLINICAL STUDY ON CONGENITAL CYTOMEGALOVIRUS INFECTION IN PEDIATRIC PATIENTS. Participate in clinical protocol site development teleconferences,… $25,000
ST Jude Children's Research Hospital Inc. TO CONDUCT A CLINICAL STUDY ON CONGENITAL CYTOMEGALOVIRUS INFECTION IN PEDIATRIC PATIENTS. The subcontractor will perform laboratory testing of protocol… $158,811
Research Institute At Nationwide Children's Hospital TO CONDUCT A CLINICAL STUDY ON CONGENITAL CYTOMEGALOVIRUS INFECTION IN PEDIATRIC PATIENTS. Participate in clinical protocol and site development, begin… -$41,000
Arkansas Children's Research Institute TO CONDUCT A CLINICAL STUDY ON CONGENITAL CYTOMEGALOVIRUS INFECTION IN PEDIATRIC PATIENTS. Participate in clinical protocol site development teleconferences,… -$41,000
Connecticut Children's Medical Center TO CONDUCT A CLINICAL STUDY ON CONGENITAL CYTOMEGALOVIRUS INFECTION IN PEDIATRIC PATIENTS. Participate in clinical protocol site development teleconferences,… $15,000
University Of Pittsburgh - Of The Commonwealth System Of Higher Education TO CONDUCT A CLINICAL STUDY ON CONGENITAL CYTOMEGALOVIRUS INFECTION IN PEDIATRIC PATIENTS. Participate in clinical protocol site development teleconferences,… $20,000
The Washington University TO CONDUCT A CLINICAL STUDY ON CONGENITAL CYTOMEGALOVIRUS INFECTION IN PEDIATRIC PATIENTS. Participate in clinical protocol site development teleconferences,… $25,000
The Charlotte-Mecklenburg Hospital Authority TO CONDUCT A CLINICAL STUDY ON CONGENITAL CYTOMEGALOVIRUS INFECTION IN PEDIATRIC PATIENTS. Participate in clinical protocol site development teleconferences,… $69,000
University Of Mississippi Medical Center IGF::OT::IGF - TARGETED CLINICAL RESEARCH TO ADDRESS SELECT VIRAL INFECTIONS Participate in clinical protocol site development teleconferences, begin patient… $38,000
University Of Utah IGF::OT::IGF - TARGETED CLINICAL RESEARCH TO ADDRESS SELECT VIRAL INFECTIONS Participate in clinical protocol site development teleconferences, begin patient… $46,455
The Washington University IGF::OT::IGF - TARGETED CLINICAL RESEARCH TO ADDRESS SELECT VIRAL INFECTIONS Participate in clinical protocol and site development teleconferences, begin… $106,405
Show all 25

Quick answers

Who was awarded contract HHSN272201600017C?

HHSN272201600017C was awarded to University Of Alabama At Birmingham by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 30, 2016.

How much is contract HHSN272201600017C worth?

The government has obligated $5,253,357 on HHSN272201600017C. Its potential value, with all options, is $11,509,618.

Was contract HHSN272201600017C competed?

The extent of competition for HHSN272201600017C was full and open competition. The government received 13 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award